Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Privigen in Pediatric CIDP
NCT03684018Phase 4Recruiting
- Sponsor
- CSL Limited
- Start
- Feb 2019
- Primary completion
- Dec 2029
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of intravenous immunoglobulin G in chronic inflammatory demyelinating polyneuropathy (CIDP), sponsored by CSL Limited. Started Feb 2019; status: recruiting.
02
Drugs
intravenous immunoglobulin G
03
Conditions
chronic inflammatory demyelinating polyneuropathy (CIDP)
Beyond the preview
Go deeper on NCT03684018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03684018.